Cabaletta Bio CABA
NASDAQ CABA
$1.52 -0.02 (-1.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cabaletta Bio (CABA) Current Leases (2024 - 2026)

Updated

Cabaletta Bio (CABA) posted Current Leases of $15.24 million for Q2 2026, down 7.2% from $16.43 million a year earlier.

Analysis

Cabaletta Bio (CABA) Current Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Cabaletta Bio's Current Leases came in at $20.76 million, up 246.6% from FY2024.

  • In prior years, Cabaletta Bio's Current Leases was $5.99 million in FY2024.
  • The Q2 2026 figure stands as the lowest quarterly Current Leases since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Cabaletta Bio 213.89 Mn -11.21 Mn - 15.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.24 Mn
Dec 31, 2025 20.76 Mn
Sep 30, 2025 17.60 Mn
Jun 30, 2025 16.43 Mn
Mar 31, 2025 15.21 Mn
Dec 31, 2024 5.99 Mn
API Access

Cabaletta Bio Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CABA&period=max&api_key=YOUR_API_KEY